Endothelin 2 (EDN2) (N-Term) Peptide
EDN2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Endothelin 2 (EDN2) products
- Endothelin 2 (EDN2)
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- MVSVPTTWCS VALALLVALH EGKGQAAATL EQPASSSHAQ GTHLRLRRCS
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-EDN2 Antibody(ARP52003_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Endothelin 2 (EDN2)
- Synonyms
- endothelin-2 Peptide, EDN2 Peptide, si:ch211-202b2.2 Peptide, ET2 Peptide, PPET2 Peptide, VIC Peptide, Et2 Peptide, ET-2 Peptide, endothelin 2 Peptide, EDN2 Peptide, edn2 Peptide, Edn2 Peptide
- Background
-
This gene encodes a member of the endothelin protein family of secretory vasoconstrictive peptides. The preproprotein is processed to a short mature form which functions as a ligand for the endothelin receptors that initiate intracellular signaling events. This gene product is involved in a wide range of biological processes, such as hypertension and ovulation.
Alias Symbols: ET2, PPET2
Protein Interaction Partner: CMA1,KEL,MME
Protein Size: 178 - Molecular Weight
- 20 kDa
- Gene ID
- 1907
- NCBI Accession
- NM_001956, NP_001947
- UniProt
- P20800
-
You are here:
